Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2186877A immunogenicity in elderly
NCT00938392Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2009
- Primary completion
- Oct 2009
- Modality
- Whole Inactivated Vaccines
- Countries
- 2
01
Overview
A Phase 3 trial of GSK2186877A in influenza, sponsored by GSK. Started Jul 2009; status: completed.
02
Drugs
GSK2186877A
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00938392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00938392.